Also see: Adobe: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES

Amgen ( AMGN) price target cut at Credit Suisse to $55 from $58 on higher agency costs, Credit Suisse said. Maintain Neutral rating.

American Express ( AXP) numbers lowered at Morgan Stanley. AXP estimates were cut through 2012, Morgan Stanley said. Company is investing in long-term growth. Overweight rating and new $51 price target.

Bank of America ( BAC) estimates reduced at Morgan Stanley BAC estimates were cut through 2012, Morgan Stanley said. Company is facing higher private-label losses. Overweight rating and $22 price target.

Comcast ( CMCSA) estimates, target raised at Morgan Stanley. Shares of CMCSA now seen reaching $25, according to Morgan Stanley. Estimates also increased, as the company is buying back more stock. Equal-weight rating.

Costco ( COST) target boosted at UBS to $73. Company should continue to deliver above-average sales growth. Neutral rating.

Fifth Third ( FITB) numbers raised at Citigroup. Shares of FITB now seen reaching $17. Estimates also increased, given better core loan trends. Hold rating.

General Electric ( GE) numbers boosted at Oppenheimer. Shares of GE now seen reaching $23. Estimates also upped, given better industrial and GE Capital results. Outperform rating.

Halliburton ( HAL) estimates upped at UBS through 2011. Company is seeing better sales and margins across the board. Buy rating and $48 price target.

Halliburton ( HAL) added to Top Picks List at FBR. $72 price target. Company should continue to grow in the domestic land market.

Henry Schein ( HSIC) numbers boosted at UBS. Shares of HSIC now seen reaching $72, according to UBS. Estimates also upped, as dental trends are improving. Neutral rating.

Hospira ( HSP) estimates, target cut at Goldman. Shares of HSP now seen reaching $65, according to Goldman Sachs. Estimates also lowered, given delays for generic Taxotere. Buy rating.

Johnson Controls ( JCI) numbers upped at Morgan Stanley. JCI estimates were boosted through 2013, Morgan Stanley said. Acquisitions are adding to earnings. Overweight rating and new $44 price target.

If you liked this article you might like

How to Get Rich Using Warren Buffett's Favorite Stock Market Indicators

How to Make Your Life Successful Just Like Billionaire Warren Buffett

Strange Days at Apple

How to Live Just Like Billionaire Warren Buffett

How to Make a Deal Like Billionaire Investor Warren Buffett